Flavia Borellini, Ph.D.

Flavia Borellini, Ph.D.

DirectoratRevolution Medicines· In proxies 2023–2025

Flavia Borellini, Ph.D. sits on 1 public board.

Experience

  1. Revolution MedicinesPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role +758%
  2. Viracta TherapeuticsPublic company · 4 yr
    • Director2021 – 2025 · 4 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?